⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
globenewswire.com
SNY
DoH and Sanofi Partner to Advance Vaccine Innovation
prnewswire.com
SNY
DoH and Sanofi Partner to Advance Vaccine Innovation
prnewswire.com
SNY
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
globenewswire.com
QNTM
SNY
BIIB
CLNN
Raymond Rodriguez-Torres Appointed First Ascent Biomedical New President to Scale Functional Precision Oncology
prnewswire.com
SNY
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
prnewswire.com
SNY
TrueLab Biopharmaceutical gibt Lizenzvereinbarung mit Bionyra Pharma über zwei monoklonale und bispezifische Antikörper der nächsten Generation zur Behandlung immunvermittelter Entzündungskrankheiten im Wert von bis zu 985 Millionen US-Dollar bekannt
prnewswire.com
SNY
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
prnewswire.com
BFLY
SNY
TrueLab Biopharmaceutical annonce la signature d'un accord de licence avec Bionyra Pharma pour deux anticorps monoclonaux et bispécifiques de nouvelle génération destinés au traitement des maladies inflammatoires à médiation immunitaire, d'une valeur
prnewswire.com
SNY
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases
businesswire.com
SNY